MedPath

Hebei Newtherapy BIo-Pharma technology Co., Ltd.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease

Phase 1
Conditions
Parkinson's Disease
First Posted Date
2018-06-08
Last Posted Date
2021-12-30
Lead Sponsor
Hebei Newtherapy BIo-Pharma technology Co., Ltd.
Target Recruit Count
20
Registration Number
NCT03550183
Locations
🇨🇳

Hebei Newtherapy BIo-Pharma Technology Co., Ltd, Shijiazhuang, Hebei, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.